Abstract
To improve the treatment of patients co-infected with multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency virus, we measured the relationship between treatment outcomes and hospital performance at four decentralised MDR-TB sites in South Africa. We describe hospital performance from the patient's perspective by the use of a graphic that visually represents a patient's treatment journey. The graphic was used to report study findings to study sites and as a catalyst for a quality improvement process.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 56-59 |
| Number of pages | 4 |
| Journal | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease |
| Volume | 17 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Infectious Diseases
Fingerprint
Dive into the research topics of 'The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS